Аннотация

Сепсиси акушерӣ ва шоки септикӣ ҳамчунон яке аз шаклҳои хатарноктарини ҳолатҳои вазнини клиникӣ дар занони ҳомила ва занони баъди таваллуд ба ҳисоб мераванд. Ҷараёни беморӣ, махсусан вақте, ки синдроми дистресси шадиди роҳи нафас (СДШРН) инкишоф меёбад, вазнин мегардад. Ин ҳолат на танҳо осеби аввалияи мембранаи алвеолавӣ-капилляриро, балки вайроншавии системавии танзими илтиҳоб, дисфунктсияи эндотелӣ, коагулопатия, ихроҷи моеъ аз капиллярҳо ва норасоии бисёриузвиро инъикос мекунад.
Дар шарҳи мазкур тасаввуроти муосир оид ба патогенез, ташхис ва табобати интенсивии СДШРН ҳангоми сепсиси акушерӣ ҷамъбаст карда шудаанд. Диққати махсус ба дастгирии муҳофизатии нафаскашӣ, табобати барвақти зиддимикробӣ, назорати манбаи сироят, устуворсозии гемодинамикӣ, тактикаи инфузионӣ-трансфузионӣ, истифодаи глюкокортикоидҳо, доруҳои зидди занбуруғӣ, пешгирии аворизи тромбоэмболӣ ва нақши усулҳои экстракорпоралӣ равона шудааст. Ҳамчунин вояҳои доруҳои асосии табобатӣ, ки аз ҷониби тавсияҳои байналмилалӣ тавсия мешаванд ва дар дастурҳои клиникии Русия истифода мегарданд, алоҳида пешниҳод шудаанд. Таъкид мешавад, ки табобати СДШРН дар занони баъди таваллуд бо сепсис набояд танҳо ҳамчун ислоҳи гипоксемия баррасӣ шавад. Он бояд ба стратегияи маҷмўӣ асос ёбад, ки шиносоии барвақти сепсис, оғози фаврии табобат, бартарафсозии манбаи сироят ва арзёбии мунтазами норасоии узвҳоро дар бар мегирад.
 

Калимаҳои калидӣ

сепсиси акушерӣ сепсиси баъди таваллуд шоки септикӣ синдроми дистресси шадиди роҳи нафас занони баъди таваллуд табобати интенсивӣ шамолдиҳии сунъии шуш антибиотикҳо норадреналин гидрокортизон.

Матни пурра

Боргирӣ кардани мақола дар PDF

Версияи пурраи мақола дар формати PDF

Феҳристи манбаъ

  1. World Health Organization. Sepsis. Fact sheet. 3 May 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/sepsis
  2. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
  3. World Health Organization. Statement on maternal sepsis. WHO/RHR/17.02. Geneva: WHO; 2017. Available from: https://www.who.int/publications/i/item/WHO-RHR-17.02
  4. World Health Organization. Maternal sepsis. Available from: https://www.who.int/teams/sexual-and-reproductive-health-and-research-(srh)/areas-of-work/maternal-and-perinatal-health/maternal-sepsis
  5. Клинические рекомендации. Послеродовые инфекционные осложнения. Минздрав России; 2024. Available from: https://diseases.medelement.com/disease/послеродовые-инфекционные-осложнения-кр-рф-2024/18091
  6. Клинические рекомендации. Сепсис у взрослых. Минздрав России; 2024. Available from: https://diseases.medelement.com/disease/сепсис-у-взрослых-кр-рф-2024/18499
  7. Surviving Sepsis Campaign. International Guidelines for Management of Sepsis and Septic Shock 2026. Society of Critical Care Medicine; 2026. Available from: https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-septic-shock-2026
  8. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181-1247. doi: 10.1007/s00134-021-06506-y.
  9. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock. JAMA. 2016;315(8):801-810. doi: 10.1001/jama.2016.0287.
  10. Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard LJ, et al. A New Global Definition of Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;209(1):37-47. doi: 10.1164/rccm.202303-0558WS.
  11. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533. doi: 10.1001/jama.2012.5669.
  12. Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023;49:727-759. doi:10.1007/s00134-023-07050-7.
  13. Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ, et al. An Official ATS/ESICM/SCCM Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253-1263. doi: 10.1164/rccm.201703-0548ST.
  14. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and ARDS. N Engl J Med. 2000;342:1301-1308. doi:10.1056/NEJM200005043421801.
  15. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159-2168. doi: 10.1056/NEJMoa1214103.
  16. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107-1116. doi: 10.1056/NEJMoa1005372.
  17. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019;380:1997-2008. doi: 10.1056/NEJMoa1901686.
  18. Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965-1975. doi: 10.1056/NEJMoa1800385.
  19. Amato MBP, Meade MO, Slutsky AS, Brochard L, Costa ELV, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372:747-755. doi: 10.1056/NEJMsa1410639.
  20. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185-2196. doi:10.1056/NEJMoa1503326.
  21. Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, Eastwood G, et al. Conservative oxygen therapy during mechanical ventilation in the ICU. N Engl J Med. 2020;382:989-998. doi: 10.1056/NEJMoa1903297.
  22. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564-2575. doi: 10.1056/NEJMoa062200.
  23. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2016. Intensive Care Med. 2017;43:304-377. doi: 10.1007/s00134-017-4683-6.
  24. RCOG. Identification and management of maternal sepsis during and following pregnancy. Green-top Guideline No. 64. Published 19 December 2024. Available from: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/identification-and-management-of-maternal-sepsis-during-and-following-pregnancy-green-top-guideline-no-64/
  25. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by IDSA. Clin Infect Dis. 2016;62(4):e1-e50. doi: 10.1093/cid/civ933.
  26. Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious MRSA infections: revised consensus guideline. Am J Health Syst Pharm. 2020;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
  27. Pfizer. Tazocin 2 g/250 mg and 4 g/500 mg powder for solution for infusion. Summary of Product Characteristics. Available from: https://labeling.pfizer.com/ShowLabeling.aspx?id=12877
  28. Pfizer. Meropenem for injection prescribing information. Available from: https://labeling.pfizer.com/ShowLabeling.aspx?id=12534
  29. NICE British National Formulary. Piperacillin with tazobactam. Available from: https://bnf.nice.org.uk/drugs/piperacillin-with-tazobactam/
  30. World Health Organization. WHO recommendations for prevention and treatment of maternal peripartum infections. Geneva: WHO; 2015. Available from: https://iris.who.int/handle/10665/186684
  31. Pek Z, Owusu-Bediako K, Rimawi BH, Chappell CA. Getting With the Times: A Review of Peripartum Infections and Proposed Modernized Treatment Regimens. Open Forum Infect Dis. 2022;9(9):ofac460. doi: 10.1093/ofid/ofac460.
  32. Manigrasso J, Bellussi F, Chappell LC. Maternal sepsis: background, diagnosis and management. BMJ Med. 2024;3:e000783. doi: 10.1136/bmjmed-2023-000783.
  33. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44:925-928. doi: 10.1007/s00134-018-5085-0.
  34. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165-228. doi: 10.1007/s00134-012-2769-8.
  35. Bauer ME, Lorenz RP, Bauer ST, Rao K, Anderson FWJ. Maternal deaths due to sepsis in the state of Michigan, 1999-2006. Obstet Gynecol. 2015;126(4):747-752. doi: 10.1097/AOG.0000000000001036.
  36. Bauer ME, Bateman BT, Bauer ST, Shanks AM, Mhyre JM. Maternal sepsis mortality and morbidity during hospitalization for delivery. Obstet Gynecol. 2013;122(5):940-947. doi: 10.1097/AOG.0b013e3182a94f11.
  37. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for innovative therapies in sepsis. Chest. 1992;101(6):1644-1655. doi: 10.1378/chest.101.6.1644.
  38. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with ARDS in intensive care units in 50 countries. JAMA. 2016;315(8):788-800. doi: 10.1001/jama.2016.0291.
  39. Munshi L, Del Sorbo L, Adhikari NKJ, Hodgson CL, Wunsch H, Meade MO, et al. Prone position for ARDS: a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(Suppl 4):S280-S288. doi: 10.1513/AnnalsATS.201704-343OT.
  40. Young P, Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, et al. Conservative oxygen therapy for mechanically ventilated adults with sepsis: ICU-ROX subgroup analysis. Intensive Care Med. 2020;46:17-26. doi: 10.1007/s00134-019-05857-9.
  41. Finfer S, Machado FR. The global epidemiology of sepsis: does it matter that we know so little? Am J Respir Crit Care Med. 2016;193(3):228-230. doi: 10.1164/rccm.201510-1976ED.
  42. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in septic shock. Crit Care Med. 2006;34(6):1589-1596. doi: 10.1097/01.CCM.0000217961.75225.E9.
  43. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75-87. doi: 10.1016/S0140-6736(18)30696-2.